{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:45:37Z","timestamp":1793857537049,"version":"4.6.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Science","doi-asserted-by":"crossref","award":["UL1TR002556"],"award-info":[{"award-number":["UL1TR002556"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Arthritis Society of Canada, Canadian Institutes of Health Research, Physician\u2019s Services Incorporated"},{"name":"Province of Ontario Early Research Award"},{"DOI":"10.13039\/100012051","name":"Lupus Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012051","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Arthritis Society, Young Investigator Award"},{"name":"Canadian Rheumatology Association\u2013Arthritis Society Clinician Investigator Award"},{"DOI":"10.13039\/501100009227","name":"Department of Medicine, University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009227","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lupus Ontario and Schroeder Arthritis Institute"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Cognitive dysfunction (CD) is a common manifestation of SLE that can have detrimental consequences for those affected. To date, no treatments have been approved for SLE-CD. This study aims to assess the association of azathioprine (AZA) and mycophenolate (MMF) use with SLE-CD, given that\u00a0these medications have demonstrated neuroprotective qualities in prior studies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Consecutive adult SLE patients presenting to a single healthcare center were considered for participation. The ACR neuropsychological battery for SLE was administered to consenting patients at 0, 6 and 12\u2009months. Scores were compared with age- and sex-matched controls. Primary outcome was CD, defined as a z-score \u2264\u22121.5 in two or more cognitive domains. Mixed-effects logistic regression models were constructed to estimate the odds of CD with respect to AZA and MMF use.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 300 participants representing 676 patient visits completed the study; 114 (38%) met criteria for CD at baseline. The cumulative AZA dose (g\/kg) was associated with reduced odds of CD [odds ratio (OR) 0.76 (95% CI 0.58, 0.98), P\u2009=\u20090.04]. Years of AZA treatment was also associated with reduced odds of CD [OR 0.72 (95% CI 0.54, 0.97), P\u2009=\u20090.03]. MMF use was not associated with CD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>AZA use was associated with significantly lower odds of SLE-CD, while MMF use was not. Additional studies are warranted to further investigate the relationship of AZA and SLE-CD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac540","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T20:19:11Z","timestamp":1663791551000},"page":"1860-1869","source":"Crossref","is-referenced-by-count":8,"title":["Association of mycophenolate and azathioprine use with cognitive function in systemic lupus"],"prefix":"10.1093","volume":"62","author":[{"given":"Chrisanna","family":"Dobrowolski","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Icahn School of Medicine at Mount Sinai , New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McGinley","sequence":"additional","affiliation":[{"name":"Department of Neurology, Albert Einstein College of Medicine , Bronx, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Fazzari","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Population Health and Department of Obstetrics and Gynecology and Women's Health, Albert Einstein College of Medicine , Bronx, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Su","sequence":"additional","affiliation":[{"name":"University of Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital , Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen S","family":"Bingham","sequence":"additional","affiliation":[{"name":"Centre for Mental Health, University Health Network; Department of Psychiatry, University of Toronto , Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Anderson","sequence":"additional","affiliation":[{"name":"University of Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital , Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Ruttan","sequence":"additional","affiliation":[{"name":"University Health Network-Toronto Rehabilitation Institute , Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorcas E","family":"Beaton","sequence":"additional","affiliation":[{"name":"Institute for Work and Health, University of Toronto , Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan E","family":"Wither","sequence":"additional","affiliation":[{"name":"University of Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital , Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carmela","family":"Tartaglia","sequence":"additional","affiliation":[{"name":"University of Toronto Krembil Neurosciences Centre , Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahta","family":"Kakvan","sequence":"additional","affiliation":[{"name":"University of Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital , Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennisse","family":"Bonilla","sequence":"additional","affiliation":[{"name":"University of Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital , Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3760-2737","authenticated-orcid":false,"given":"May Y","family":"Choi","sequence":"additional","affiliation":[{"name":"Cumming School of Medicine, University of Calgary , Calgary, AB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1652-6608","authenticated-orcid":false,"given":"Marvin J","family":"Fritzler","sequence":"additional","affiliation":[{"name":"Cumming School of Medicine, University of Calgary , Calgary, AB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Diaz Martinez","sequence":"additional","affiliation":[{"name":"University of Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital , Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Katz","sequence":"additional","affiliation":[{"name":"University of California, San Francisco , Novato, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Green","sequence":"additional","affiliation":[{"name":"University Health Network-Toronto Rehabilitation Institute , Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaim","family":"Putterman","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Albert Einstein School of Medicine , Bronx, NY, USA"},{"name":"Division of Rheumatology, Albert Einstein College of Medicine , Bronx, NY, USA"},{"name":"Azrieli School of Medicine , Safed, Israel"},{"name":"Galillee Medical Center , Nahariya, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5177-2076","authenticated-orcid":false,"given":"Zahi","family":"Touma","sequence":"additional","affiliation":[{"name":"University of Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital , Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,9,22]]},"reference":[{"key":"2023050208171951700_keac540-B1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/1529-0131(200110)45:5<419::AID-ART360>3.0.CO;2-X","article-title":"Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation","volume":"45","author":"Ainiala","year":"2001","journal-title":"Arthritis Rheum"},{"key":"2023050208171951700_keac540-B2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.semarthrit.2018.02.007","article-title":"What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis","volume":"48","author":"Rayes","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"2023050208171951700_keac540-B3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/14397595.2019.1589912","article-title":"Prevalence, outcome and prognostic factors of neuropsychiatric systemic lupus erythematosus: a real world single center study","volume":"30","author":"Li","year":"2020","journal-title":"Mod Rheumatol"},{"key":"2023050208171951700_keac540-B4","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/rheumatology\/41.11.1308","article-title":"Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality","volume":"41","author":"Jonsen","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"2023050208171951700_keac540-B5","article-title":"Cognitive impairment and health-related quality of life in a lupus cohort","volume":"70(Suppl 10)","author":"Dobrowolski","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2023050208171951700_keac540-B6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/03009742.2016.1206617","article-title":"Impact of cognitive impairment, depression, disease activity, and disease damage on quality of life in women with systemic lupus erythematosus","volume":"46","author":"Calderon","year":"2017","journal-title":"Scand J Rheumatol"},{"key":"2023050208171951700_keac540-B7","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/art.23090","article-title":"Impact of memory impairment on employment status in persons with systemic lupus erythematosus","volume":"57","author":"Panopalis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2023050208171951700_keac540-B8","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/art.24346","article-title":"Cognitive impairment and employment status in systemic lupus erythematosus: a prospective longitudinal study","volume":"61","author":"Appenzeller","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2023050208171951700_keac540-B9","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.semarthrit.2021.09.008","article-title":"Longitudinal relationships between cognitive domains and DEPRESSION and anxiety symptoms in systemic lupus erythematosus","volume":"51","author":"Bingham","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"2023050208171951700_keac540-B10","first-page":"SI34","article-title":"The effects of disease activity, inflammation, depression and cognitive fatigue on resting state fMRI in systemic lupus erythematosus","volume":"61(SI)","author":"Barraclough","year":"2022","journal-title":"Rheumatology (Oxford)."},{"key":"2023050208171951700_keac540-B11","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/art.40933","article-title":"Cognitive dysfunction in systemic lupus erythematosus: a case for initiating trials","volume":"71","author":"Kello","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2023050208171951700_keac540-B12","author":"Mackay","year":"(29  2022,   )"},{"key":"2023050208171951700_keac540-B13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.semarthrit.2020.12.004","article-title":"Management of inflammatory neurologic and psychiatric manifestations of systemic lupus erythematosus: a systematic review","volume":"51","author":"Papachristos","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"2023050208171951700_keac540-B14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/practneurol-2017-001743","article-title":"Neuropsychological testing","volume":"18","author":"Zucchella","year":"2018","journal-title":"Pract Neurol"},{"key":"2023050208171951700_keac540-B15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/13854046.2020.1722244","article-title":"American Academy of Clinical Neuropsychology consensus conference statement on uniform labeling of performance test scores","volume":"34","author":"Guilmette","year":"2020","journal-title":"Clin Neuropsychol"},{"key":"2023050208171951700_keac540-B16","first-page":"1776","article-title":"Cognitive function in a systemic lupus erythematosus inception cohort","volume":"35","author":"Petri","year":"2008","journal-title":"J Rheumatol"},{"key":"2023050208171951700_keac540-B17","article-title":"Prevalence of cognitive impairment in systemic lupus erythematosus assessed by a comprehensive neuropsychological battery","volume":"69(Suppl 10)","author":"Touma","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2023050208171951700_keac540-B18","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/acr.24096","article-title":"Validity evidence for the use of automated neuropsychologic assessment metrics as a screening tool for cognitive impairment in systemic lupus erythematosus","volume":"72","author":"Tayer-Shifman","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2023050208171951700_keac540-B19","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/art.20692","article-title":"Reliability and validity of the proposed American College of Rheumatology neuropsychological battery for systemic lupus erythematosus","volume":"51","author":"Kozora","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2023050208171951700_keac540-B20","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.3899\/jrheum.161125","article-title":"Performance of screening tests for cognitive impairment in systemic lupus erythematosus","volume":"44","author":"Nantes","year":"2017","journal-title":"J Rheumatol"},{"key":"2023050208171951700_keac540-B21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41584-018-0156-8","article-title":"Neuropsychiatric lupus: new mechanistic insights and future treatment directions","volume":"15","author":"Schwartz","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"2023050208171951700_keac540-B22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fncel.2013.00044","article-title":"Factors regulating microglia activation","volume":"7","author":"Kierdorf","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"2023050208171951700_keac540-B23","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12974-017-0998-z","article-title":"Inhibiting the microglia activation improves the spatial memory and adult neurogenesis in rat hippocampus during 48 h of sleep deprivation","volume":"14","author":"Wadhwa","year":"2017","journal-title":"J Neuroinflammation"},{"key":"2023050208171951700_keac540-B24","doi-asserted-by":"crossref","first-page":"31545","DOI":"10.1038\/srep31545","article-title":"Elimination of microglia improves cognitive function following cranial irradiation","volume":"6","author":"Acharya","year":"2016","journal-title":"Sci Rep"},{"key":"2023050208171951700_keac540-B25","doi-asserted-by":"crossref","first-page":"8889","DOI":"10.1523\/JNEUROSCI.0789-18.2018","article-title":"Microglia play an active role in obesity-associated cognitive decline","volume":"38","author":"Cope","year":"2018","journal-title":"J Neurosci"},{"key":"2023050208171951700_keac540-B26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/jnc.13607","article-title":"Neuroinflammation: the devil is in the details","volume":"139(Suppl 2)","author":"DiSabato","year":"2016","journal-title":"J Neurochem"},{"key":"2023050208171951700_keac540-B27","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1365-2990.2010.01104.x","article-title":"Inhibition of microglial and astrocytic inflammatory responses by the immunosuppressant mycophenolate mofetil","volume":"36","author":"Dehghani","year":"2010","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2023050208171951700_keac540-B28","doi-asserted-by":"crossref","first-page":"E5986","DOI":"10.1073\/pnas.1706778114","article-title":"Highly selective inhibition of IMPDH2 provides the basis of antineuroinflammation therapy","volume":"114","author":"Liao","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023050208171951700_keac540-B29","first-page":"170","article-title":"Neurotoxicity of immunosuppressive therapies in organ transplantation","volume":"8","author":"Anghel","year":"2013","journal-title":"Maedica (Buchar)"},{"key":"2023050208171951700_keac540-B30","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1046\/j.1460-9568.2003.02821.x","article-title":"The immunosuppressant mycophenolate mofetil attenuates neuronal damage after excitotoxic injury in hippocampal slice cultures","volume":"18","author":"Dehghani","year":"2003","journal-title":"Eur J Neurosci"},{"key":"2023050208171951700_keac540-B31","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.3390\/ijms20133210","article-title":"Recent topics on the mechanisms of immunosuppressive therapy-related neurotoxicities","volume":"20","author":"Zhang","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2023050208171951700_keac540-B32","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12974-016-0543-5","article-title":"6-Mercaptopurine attenuates tumor necrosis factor-\u03b1 production in microglia through Nur77-mediated transrepression and PI3K\/Akt\/mTOR signaling-mediated translational regulation","volume":"13","author":"Huang","year":"2016","journal-title":"J Neuroinflammation"},{"key":"2023050208171951700_keac540-B33","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2023050208171951700_keac540-B34","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch Gen Psychiatry"},{"key":"2023050208171951700_keac540-B35","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring clinical anxiety: psychometric properties","volume":"56","author":"Beck","year":"1988","journal-title":"J Consult Clin Psychol"},{"key":"2023050208171951700_keac540-B36","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1076\/clin.13.3.348.1749","article-title":"Construct and concurrent validity of the Hopkins Verbal Learning Test\u2013revised","volume":"13","author":"Shapiro","year":"1999","journal-title":"Clin Neuropsychol"},{"key":"2023050208171951700_keac540-B37","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/acr.24261","article-title":"Identifying a response for the Systemic Lupus Erythematosus Disease Activity Glucocorticoid Index (SLEDAI-2KG)","volume":"73","author":"Touma","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2023050208171951700_keac540-B38","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/rheumatology\/key103","article-title":"A novel lupus activity index accounting for glucocorticoids: SLEDAI-2K glucocorticoid index","volume":"57","author":"Touma","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2023050208171951700_keac540-B39","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum"},{"key":"2023050208171951700_keac540-B40","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/rheumatology\/35.3.248","article-title":"SLICC\/ACR Damage Index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus","volume":"35","author":"Stoll","year":"1996","journal-title":"Br J Rheumatol"},{"key":"2023050208171951700_keac540-B41","first-page":"22","article-title":"The cognitive consequences of obesity","volume":"March\/April","author":"Devere","year":"2018","journal-title":"Pract Neurol"},{"key":"2023050208171951700_keac540-B42","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11065-007-9035-9","article-title":"The effects of tobacco smoke and nicotine on cognition and the brain","volume":"17","author":"Swan","year":"2007","journal-title":"Neuropsychol Rev"},{"key":"2023050208171951700_keac540-B43","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.autrev.2016.09.002","article-title":"Cognitive disorders and antiphospholipid antibodies","volume":"15","author":"Yelnik","year":"2016","journal-title":"Autoimmun Rev"},{"key":"2023050208171951700_keac540-B44","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/geront\/gnx142","article-title":"Racial\/ethnic and nativity differences in cognitive life expectancies among older adults in the United States","volume":"59","author":"Garcia","year":"2019","journal-title":"Gerontologist"},{"key":"2023050208171951700_keac540-B45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2147\/NRR.S115625","article-title":"The impact of employment on cognition and cognitive reserve: implications across diseases and aging","volume":"6","author":"Vance","year":"2016","journal-title":"Nurs Res Rev"},{"key":"2023050208171951700_keac540-B46","doi-asserted-by":"crossref","first-page":"b2462","DOI":"10.1136\/bmj.b2462","article-title":"Association between mid-life marital status and cognitive function in later life: population based cohort study","volume":"339","author":"Hakansson","year":"2009","journal-title":"BMJ"},{"key":"2023050208171951700_keac540-B47","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.4103\/0976-500X.120975","article-title":"Corticosteroid-related central nervous system side effects","volume":"4(Suppl 1)","author":"Ciriaco","year":"2013","journal-title":"J Pharmacol Pharmacother"},{"key":"2023050208171951700_keac540-B48","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/ard.2010.130476","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs","volume":"69","author":"Bertsias","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2023050208171951700_keac540-B49","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1017\/cjn.2018.326","article-title":"Mycophenolate mofetil-induced status epilepticus","volume":"45","author":"Pellerin","year":"2018","journal-title":"Can J Neurol Sci"},{"key":"2023050208171951700_keac540-B50","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41584-020-0374-8","article-title":"Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology","volume":"16","author":"Broen","year":"2020","journal-title":"Nat Rev Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac540\/46572038\/keac540.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/5\/1860\/50120839\/keac540.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/5\/1860\/50120839\/keac540.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T08:23:14Z","timestamp":1683015794000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/5\/1860\/6711386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,22]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,9,22]]},"published-print":{"date-parts":[[2023,5,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac540","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,5,1]]},"published":{"date-parts":[[2022,9,22]]}}}